December 13, 2007 – The Cardiovascular Research Foundation and colleagues, along with Gregg W. Stone, M.D., of Columbia University Medical Center, examined the one-year clinical outcomes of patients enrolled in ACUITY trial and found similar outcomes for ACS patients treated with different anticoagulant regimens.

December 13, 2007 - World Heart Corp., a developer of implantable mechanical circulatory support systems for chronic heart failure patients, announced its strategic alliance with Abiomed Inc., a leading manufacturer of devices for acute circulatory support.

FlowCardia's three peripheral CROSSER Catheters — CROSSER 14P, CROSSER 14S and CROSSER 18 CTO Recanalization — are endovascular tools used by interventional radiologists, vascular surgeons and interventional cardiologists to cross CTOs to help restore blood flow to the lower legs. The CROSSER is a rapid exchange catheter delivered over standard .014 inch and .018 inch guide wires that utilizes high frequency vibration to cross CTOs, reportedly allowing for subsequent debulking, balloon angioplasty and stent placement.

www.flowcardia.com

December 12, 2007 - Over 200 surgeons, biomedical engineers and heart device executives gathered at the University of Utah on Nov. 30 and Dec. 1 to celebrate the first implant of the Jarvik 7 artificial heart on Dec. 1, 1982, and to present the current state of artificial heart pumping technology.
Today, the modern version of the Jarvik 7, SynCardia Systems’ CardioWest temporary Total Artificial Heart (TAH-t) artificial heart, is the first and only temporary artificial heart to receive FDA, Health Canada and CE approval.

December 12, 2007 - LUMEDX Corp. has introduced CardioManager Performance Management System cardiology software that reportedly translates complex clinical, operational and financial data into accessible, actionable information.

December 12, 2007 - Immersion Medical announced the launch of its new Transcatheter Aortic Valve module for its CathLabVR Surgical Simulator that helps train physicians for minimally invasive coronary valve replacement.

An estimated 450,000 patients in the U.S. suffer from severe stenosis of coronary valves, and many see valve replacement interventions as the future standard of care for many high-risk patients. Immersion Medical's new cardiac surgical simulation module is said to help accelerate learning and adoption of these minimally invasive life-saving procedures.

December 12, 2007 – When 2007 Cardiometabolic Health Congress participants were asked what guidelines they follow for treating patients with multiple cardiovascular and metabolic risk factors, the largest group of respondents indicated that they didn’t follow any particular set of guidelines and that better guidelines are needed.

The survey queried more than 750 cardiology, endocrinology, nephrology, and primary care clinicians who attended the 2007 Cardiometabolic Health Congress in September.

December 12, 2007 - Representatives Carolyn McCarthy (D-NY) Joseph Pitts (R-PA) and Gene Green (D-TX) were joined by more than 65 of their colleagues in urging Speaker of the House Nancy Pelosi to reject any additional cuts to Medicare medical imaging services.

December 11, 2007 - ValveXchange, developer of a next-generation replacement heart valve technology, won the third annual Faegre & Benson Venture Showcase Award at the BioWest 2007 Conference & Expo in Denver.
The Venture Showcase Award was provided by the Faegre & Benson law firm and announced at the Colorado Bioscience Association (CBSA) Awards Luncheon.

December 11, 2007 – Due to the loss of more than 50 percent of the North American Mo-99 supply and its impact on the ability of physicians to perform diagnostic cardiac nuclear medicine studies that depend on a reliable daily supply of isotope Technetium (Tc-99m), The American College of Radiology is investigating how it may be of service to radiologists and other nuclear medicine providers.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now